Swabs and Viral Transport Media Market

Future Market Insights (FMI) has released a new analysis that shows promising growth for the global swab and viral transport media market. According to FMI’s market attractiveness analysis, the global market is expected to grow by approximately 8.86 billion US dollars by the end of 2023. The market is expected to grow at a robust compound annual growth rate (CAGR) of 5.8%and exceeds 15.60 billion US dollars until 2033.

This significant growth curve highlights the increasing demand for swabs and viral transport media, driven by their crucial role in diagnostic testing and disease management. The rise in global healthcare initiatives, increased awareness of infectious diseases, and advancements in diagnostic technologies are key factors contributing to this market expansion.

The analysis highlights the evolving needs of healthcare providers and the growing importance of accurate and efficient testing procedures. As the market evolves, there are significant opportunities for growth and innovation for stakeholders and industry players.

Swab and viral transport media companies are producing innovative kits with vials, double-sided flocked swabs, medications and other items that prevent bacterial or fungal contamination. They are focusing on better solution formulation to stop the growth of bacterial and fungal flora. The market is growing thanks to new viral transport media solutions.

Another element driving market growth is the rising number of novel viruses that can infect humans and cause a variety of diseases. According to a 2021 article in Nature, certain respiratory viruses are reemerging in unexpected ways as pandemic restrictions are eased. Infections with respiratory syncytial virus (RSV), which is responsible for 5% of all child deaths globally, began to rise in April 2021. Due to the increased need for sample collection kits and diagnostics, the prevalence of additional infectious diseases is expected to drive market growth.

With the onset of flu season, manufacturers are developing viral transport media for flu diagnostics. Healthcare in Western countries is extremely concerned about the morbidity and death caused by flu. To provide swabs and viral transport media, manufacturers are expanding their research and development capabilities. Manufacturers are also realizing the advantages of online pharmacies over hospitals and pharmacies. To expand their revenue streams, they are collaborating with established e-commerce companies.

North America is expected to dominate the global market during the forecast period due to its highly developed medical infrastructure and high incidence of contagious diseases. During the pandemic, North America witnessed a rise in laboratory testing, which drove the market expansion. The market is also growing significantly due to the existence of biopharmaceutical companies, a large number of laboratories, and research studies on viral infections.

Key findings

• The UK market is expected to grow and have a compound annual growth rate of 9%until 2033.
• The United States is expected to1%CAGR during the forecast period.
• With a CAGR of 0%During the forecast period, Canada’s market is expected to experience rapid development.
• In China, the market is expected to grow, with an average annual growth rate of 7%over the forecast period.
• Germany is expected to grow at a decent rate, with an average annual growth rate of 7% until 2033.

Competitive environment

The major players in the Swabs and Viral Transport Media market are McKesson Corporation, Cardinal Health Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Quidel Corporation, COPAN Diagnostics Inc., VIRCELL SL, Deltalab, Titan Biotech Ltd., Medical Wire & Equipment and others.

These market players are constantly inventing and developing new products to meet the diverse needs of diagnostic laboratories and research institutions. They are improving the design and components of swabs to increase their effectiveness in sample collection. They are also developing transport media that can store virus samples for longer periods of time without affecting their vitality. They are also combining advanced technologies to improve the stability and accuracy of diagnostic samples.

Recent developments

• In June 2022, Zipline and Cardinal Health announced the start of long-distance drone deliveries in North Carolina.
• In May 2020, Health Mart® pharmacies in several pharmacies across the United States announced they would provide free COVID-19 testing. Health Mart, as a member of McKesson Corporation, is committed to creating innovative public and private collaborations to combat the COVID-19 epidemic.

Other major players in the swab and virus transport market

• Thermo Fisher Scientific Inc.,
• Quidel Corporation,
• COPAN Diagnostics Inc.,
• VIRCELL SL, Deltalab,
• Titan Biotech Ltd.,
• Medical lines and devices

Swabs and Viral Transport Media Market by Category

By product:

• Viral transport medium
  • Tissue culture medium
  • Glycerin transport medium
• Virus swabs
  • Nasopharyngeal swabs
  • Deep nasal swabs
  • Combined nasal and throat swabs
  • Cultural smears
  • Vaginal swabs

After application:

• flu
• Respiratory syncytial virus
• Mumps virus
• Adenovirus
• Rhinovirus
• Herpes simplex virus
• Varicella-zoster virus
• Other indication

By end user:

• Hospitals and ASCs
• Special clinics
• Diagnostic laboratories
• Miscellaneous

author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) has over 12 years of experience in healthcare, medical device and pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying clients' key challenges and developing robust, hypothesis-based solutions that give them strategic decision-making authority comes naturally to him. His main skills lie in areas such as market entry and expansion strategies, feasibility studies, competitive analysis and strategic transformation.

Sabyasachi holds a degree in microbiology and is the author of numerous publications and has been cited in peer-reviewed journals including The Journal of mHealth, ITN Online and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award recipient and member of the Greater New York Chamber of Commerce) provides in-depth insights into the driving factors that are driving demand in the market. FMI is the world's leading provider of market intelligence, advisory services, consulting and events for the packaging, food and beverage, consumer technology, healthcare, industrial and chemical markets. With a huge team of over 400 analysts worldwide, FMI offers global, regional and local expertise on various domains and industry trends in more than 110 countries.

Contact:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
Phone: +1-845-579-5705
For sales inquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Þjórsárden| Blog | YouTube